Form 4: Guardant Health Director Converts RSUs to Common Stock

Sentiment:

Insider Transaction Report


Guardant Health Director Manuel Hidalgo Medina converted 232 restricted stock units into common stock on January 17, 2026.

Summary

  • Manuel Hidalgo Medina, a Director at Guardant Health, Inc., reported a change in beneficial ownership.
  • On January 17, 2026, Medina acquired 232 shares of Guardant Health Common Stock.
  • This acquisition resulted from the conversion of 232 Restricted Stock Units (RSUs) at a price of $0.
  • Following this transaction, Medina directly owns 1,261 shares of Common Stock.
  • Medina also beneficially owns 6,961 Restricted Stock Units.
  • The RSUs involved in this transaction were part of an award granted on July 17, 2024, with a vesting schedule of 25% on the one-year anniversary (July 17, 2025) and the remaining 75% vesting monthly over the subsequent three years.

Sentiment

Score: 6

Explanation: A director increasing direct stock ownership through RSU conversion is generally a neutral to slightly positive signal, indicating continued alignment with shareholder interests, but it's a routine compensation event rather than a discretionary purchase.

Positives

  • Director Manuel Hidalgo Medina increased his direct ownership of common stock by 232 shares, which can be seen as a positive alignment of interests with shareholders.

Future Outlook

This filing reports a past insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is a routine insider transaction report, which typically does not provide broader industry context. It reflects a director's compensation-related stock activity rather than a strategic industry move.

Stakeholder Impact

  • Shareholders: Increased direct ownership by a director may be viewed positively as it aligns management interests with shareholder interests.

Next Steps

  • The remaining 75% of the RSU award granted on July 17, 2024, will continue to vest monthly over a three-year period following July 17, 2025.

Key Dates

DateDescription
07/17/2024Grant date of the restricted stock unit award to Manuel Hidalgo Medina.
07/17/2025One-year anniversary of the RSU grant, when 25% of the award vested.
01/17/2026Date of transaction where 232 Restricted Stock Units were converted into Common Stock.
01/20/2026Date the Form 4 was signed by the attorney-in-fact for Manuel Hidalgo Medina.

Recommendation

hold

This Form 4 reports a routine insider transaction where a director converted restricted stock units into common stock. While an increase in direct ownership can be seen as a positive alignment of interests, it's a standard compensation event rather than a discretionary open-market purchase. The transaction itself does not provide new fundamental information to warrant a change in investment recommendation, thus a 'hold' stance is maintained.

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director Ownership, Manuel Hidalgo Medina

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.